COMMODORE CAPITAL LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | RLAY | 17.00M | $88.74M |
 | CTMX | 7.69M | $24.54M |
 | COGT | 7.25M | $104.11M |
 | TERN | 5.70M | $42.81M |
 | IKT | 5.40M | $8.74M |
 | ELVN | 4.69M | $96.06M |
 | SABS | 4.40M | $8.85M |
 | AMLX | 4.08M | $55.39M |
 | NRIX | 3.78M | $34.93M |
 | MRUS | 3.52M | $331.88M |
 | TYRA | 3.38M | $47.22M |
 | MNMD | 3.23M | $38.02M |
 | VRDN | 3.20M | $69.06M |
 | ALKS | 3.10M | $92.90M |
 | CLDX | 3.03M | $78.34M |
 | CNTA | 2.85M | $69.11M |
 | XENE | 2.70M | $108.41M |
 | PHVS | 2.42M | $60.34M |
 | PEPG | 2.36M | $10.89M |
 | AGIO | 2.34M | $93.86M |
Relay Therapeutics, Inc.
RLAY
Shares Held
17.00M
Value
$88.74M
CytomX Therapeutics, Inc.
CTMX
Shares Held
7.69M
Value
$24.54M
Cogent Biosciences, Inc.
COGT
Shares Held
7.25M
Value
$104.11M
Terns Pharmaceuticals, Inc.
TERN
Shares Held
5.70M
Value
$42.81M
Inhibikase Therapeutics, Inc.
IKT
Shares Held
5.40M
Value
$8.74M
Enliven Therapeutics, Inc.
ELVN
Shares Held
4.69M
Value
$96.06M
SAB Biotherapeutics, Inc.
SABS
Shares Held
4.40M
Value
$8.85M
Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
4.08M
Value
$55.39M
Nurix Therapeutics, Inc.
NRIX
Shares Held
3.78M
Value
$34.93M
Merus N.V.
MRUS
Shares Held
3.52M
Value
$331.88M
Tyra Biosciences, Inc.
TYRA
Shares Held
3.38M
Value
$47.22M
Mind Medicine (MindMed) Inc.
MNMD
Shares Held
3.23M
Value
$38.02M
Viridian Therapeutics, Inc.
VRDN
Shares Held
3.20M
Value
$69.06M
Alkermes plc
ALKS
Shares Held
3.10M
Value
$92.90M
Celldex Therapeutics, Inc.
CLDX
Shares Held
3.03M
Value
$78.34M
Centessa Pharmaceuticals plc
CNTA
Shares Held
2.85M
Value
$69.11M
Xenon Pharmaceuticals Inc.
XENE
Shares Held
2.70M
Value
$108.41M
Pharvaris N.V.
PHVS
Shares Held
2.42M
Value
$60.34M
PepGen Inc.
PEPG
Shares Held
2.36M
Value
$10.89M
Agios Pharmaceuticals, Inc.
AGIO
Shares Held
2.34M
Value
$93.86M